Clinical Trial Update: Assessing the Impact of Pioglitazone on Skin Barrier Function in Atopic Dermatitis Patients [NA]

View source ↗

Summary

The clinical trial evaluating pioglitazone for skin barrier function in atopic dermatitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: University of Rochester | Conditions: Atopic Dermatitis | NA | Status: WITHDRAWN